Bio Green Med Solution, Inc. (BGMS) vs Cardio Diagnostics Holdings, Inc. (CDIO)

Bio Green Med Solution, Inc. and Cardio Diagnostics Holdings, Inc. are both Biotechnology companies. Bio Green Med Solution, Inc. and Cardio Diagnostics Holdings, Inc. are of similar size ($5.5M and $5.2M). Bio Green Med Solution, Inc. grew revenue faster over the last twelve months: 2,414.9% against −25.1%. Bio Green Med Solution, Inc. has the higher net margin (−715.5% vs −44,312.3%) and the higher return on invested capital (−67.3% vs −219.4%). Across the 16 metrics below, Bio Green Med Solution, Inc. leads on 9 and Cardio Diagnostics Holdings, Inc. on 7.

Valuation

Metric BGMS CDIO Biotechnology median
P/E n/m n/m 8.50
P/S 2.74 342.57 9.71
P/B 0.71 0.67 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.10 0.64
EV/Sales 0.70 (40.08) 9.21
Earnings yield (400.00%) (172.78%) (33.15%)
Free cash flow yield (19.67%) (116.45%) (25.50%)

Profitability

Metric BGMS CDIO Biotechnology median
Gross margin 19.34% 100.00% 65.16%
Operating margin (194.95%) (44,230.82%) 0.00%
Net margin (715.48%) (44,312.33%) 0.00%
Free cash flow margin (59.00%) (39,893.15%) 0.00%
Return on equity (246.85%) (75.44%) (56.36%)
Return on assets (217.30%) (70.62%) (48.04%)
Return on invested capital (67.28%) (219.40%) 0.00%

Growth

Metric BGMS CDIO Biotechnology median
Revenue growth (TTM) 2,414.86% (25.13%) 6.02%
EPS growth (last fiscal year) 98.71% 60.15% 30.26%
Revenue growth, 5-year CAGR (17.41%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BGMS CDIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.63 17.15 4.72
Net debt to EBITDA 0.42 0.84 0.96

Dividend

Metric BGMS CDIO Biotechnology median
Dividend yield 0.00% — 0.09%
Payout ratio — — —

Size

Metric BGMS CDIO Biotechnology median
Market cap 5.51m 5.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack